dievini Hopp BioTech holding GmbH & Co. KG
  • Welcome
  • Management
  • Portfolio
  • News
  • Imprint
  • Data Protection
  • Deutsch
dievini Hopp BioTech holding GmbH & Co. KG
  • Welcome
  • Management
  • Portfolio
  • News
  • Imprint
  • Data Protection
  • Deutsch

November 19, 2021: Cosmo Pharmaceuticals NV

DETECT study shows AI assistance using GI Genius™ reduces missed polyp rate by nearly 50% on initial colonoscopy

Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced topline results from a randomized, international, multi-center study evaluating the safety and efficacy of artificial intelligence (AI) device GI Genius™ as an aid for the detection of colorectal polyps in combination with colonoscopy. The DETECT study was designed to provide evidence of the advantages of using GI Genius™ in the real-time detection of colorectal polyps and to assess if the use of GI Genius™ would decrease the miss rates of colorectal polyps and adenomas when compared to white light endoscopy.

Please read the whole article here

Cosmo Pharmaceuticals NV, News 2021
November 18, 2021: CureVac AG
November 25, 2021: Molecular Health GmbH

dievini Hopp BioTech holding GmbH & Co. KG | Impressum | Datenschutz